证券代码：601619 证券简称：嘉泽新能 公告编号：2025-122 债券代码：113039 债券简称：嘉泽转债 嘉泽新能源股份有限公司 嘉泽新能源股份有限公司（以下简称"公司"或"嘉泽新能"） 三届十八次董事会、2023 年第一次临时股东大会审议通过了《关于 公司、一级全资子公司与国电投清洁能源基金管理有限公司下属公司 共同设立新能源资产并购基金的议案》，具体内容详见公司于 2023 年 2 月 23 日在上海证券交易所网站（http://www.sse.com.cn/）及 《中国证券报》《上海证券报》《证券时报》《证券日报》上披露的 《宁夏嘉泽新能源股份有限公司关于与国电投清洁能源基金管理有 限公司下属公司共同设立新能源资产并购基金的公告》（公告编号： 2023-012）。 公 司 于 2024 年 9 月 14 日 在 上 海 证 券 交 易 所 网 站 （http://www.sse.com.cn/）及《中国证券报》《上海证券报》《证 券时报》《证券日报》上披露了《嘉泽新能源股份有限公司关于吉林 省嘉泽清能股权投资合伙企业（有限合伙）普通合伙人退伙暨进展情 况公告》（公告编号：2024-054）。 ...

12月25日，嘉泽新能大宗交易成交302.56万股，成交额1255.62万元，占当日总成交额的5.85%，成交价 4.15元，较市场收盘价4.6元折价9.78%。 | A 200 million Julia 11 th Person | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 交易日期 | 证券简称 | 证券代码 | 成交价(元) 成交金额(万元) 成交量( *) 买入营业部 | | | | 卖出营业部 | 是否为专场 | | 025-12-25 | 直泽新能 | 601619 | 4.15 1255.62 | 302.56 | 里希望最新登花 | 塑膠影 | | ка | ...

Group 1 - The core viewpoint of the news is that 嘉泽新能 (Jiaze New Energy) has experienced fluctuations in its stock price and trading activity, with a notable increase in stock price year-to-date but a recent decline in trading performance [1] - As of December 23, 嘉泽新能's stock price is 4.50 yuan per share, with a market capitalization of 13.107 billion yuan and a trading volume of 75.332 million yuan [1] - The company has seen a year-to-date stock price increase of 42.41%, with a 0.00% change over the last five trading days and a 6.13% increase over the last 20 days [1] Group 2 - 嘉泽新能 is primarily engaged in the development, construction, operation, and sale of renewable energy power plants, with 93.64% of its revenue coming from this segment [2] - The company was established on April 16, 2010, and went public on July 20, 2017, with its operations based in Yinchuan, Ningxia Hui Autonomous Region [2] - As of September 30, 嘉泽新能 reported a revenue of 1.864 billion yuan for the first nine months of 2025, reflecting a year-on-year growth of 2.66%, and a net profit of 595 million yuan, up 7.99% year-on-year [2] Group 3 - 嘉泽新能 has distributed a total of 1.495 billion yuan in dividends since its A-share listing, with 905 million yuan distributed over the past three years [3] - As of September 30, 2025, the number of shareholders has increased by 55.46% to 97,600, while the average circulating shares per person decreased by 35.67% to 24,947 shares [2][3] - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited holds 28.2049 million shares, an increase of 2.2241 million shares compared to the previous period [3]

| 交易日期 | 证券简称 | 证券代码 | 成交价(元) | 成交金额(万元) | 成交量(*) 买入营业部 | | 卖出营业部 | | --- | --- | --- | --- | --- | --- | --- | --- | | 2025-12-16 | 嘉泽新能 | SISTA | 4.14 | 2220.53 | 536.36 | 友址夺股份有限 | 小雪缘 > | | 2025-12-16 | 嘉泽新能 | SISTA | 4.14 | 1461.71 | 353.07 | 发生有限 | _发证券股份有限 | 12月16日，嘉泽新能大宗交易成交889.43万股，成交额3682.24万元，占当日总成交额的8.25%，成交价4.14元，较市场收盘价4.5元折价8%。 ...

Group 1 - The company, Jiaze New Energy, announced plans to invest approximately 2.366 billion yuan in two wind power projects, with the Dunhua Zerui New Energy 300MW project estimated at 1.631 billion yuan and the Longan Banlan 150MW project at 735 million yuan [1] - Additionally, the company plans to invest 3.557 billion yuan in a green hydrogen and methanol aviation fuel co-production project in Jixi City, Heilongjiang Province, entering the green chemical sector [1] - The two wind power projects are located in the Changbai Mountain area of Jilin and the Liuzhou mountainous region of Guangxi, utilizing large-capacity wind turbines of 7.7 MW and 7.5 MW respectively to enhance power generation efficiency [1] Group 2 - The company has established a comprehensive development framework in the green energy sector, including five key areas: renewable energy power station development, operation and management services, distributed rooftop photovoltaics, renewable energy industry funds, and equipment manufacturing [2] - Wind power serves as the foundation of the company's development, leveraging policy advantages from the "West-to-East Power Transmission" strategy in Ningxia, and employing a unique "full lifecycle + guaranteed power generation" operational model [2] - As of June this year, the company has a total installed capacity of 2.32 GW, with over 2 GW from wind power, 30 MW from centralized photovoltaics, and 238.268 MW from distributed rooftop photovoltaics, along with 150 MW/300 MWh of grid-connected energy storage projects [2]

Core Viewpoint - The company Jiaze New Energy (601619) announced plans to invest in a green hydrogen and methanol production project in Jidong County, Jixi City, Heilongjiang Province, with a total investment of approximately 3.557 billion yuan [1] Investment Project Details - The project aims to produce 300,000 tons per year of green methanol using non-food biomass such as straw and corn cobs as raw materials [1] - The production process involves converting lignin from biomass through various methods including steam explosion, enzymatic hydrolysis, separation, and pulping to create biomass slurry, which is then gasified to produce synthesis gas [1] - The synthesis gas undergoes further processing including conversion, desulfurization, decarbonization, and methanol synthesis to produce green methanol, while cellulose by-products are fermented to produce green ethanol [1] Project Timeline - Construction is scheduled to begin in May 2026, with all construction and equipment installation expected to be completed by October 2027 [1] - The project is planned to enter the commissioning phase after installation and is expected to start production by the end of 2027 [1]

Group 1 - Anbotong plans to issue H-shares and list on the Hong Kong Stock Exchange, with the board authorizing management to start preparations within 12 months [1] - Xiangsheng Medical proposes a cash dividend of 3 yuan per 10 shares for the first three quarters of 2025 [2] - Junshi Biosciences receives FDA approval for clinical trials of JS212, a dual-specific antibody-drug conjugate for treating advanced solid tumors [3] Group 2 - Zhonghuan Environmental plans to raise up to 300 million yuan by issuing shares to a specific entity, with funds allocated for working capital and bank loan repayment [4] - Guao Technology announces a change in actual control to Xu Yinghui, with stock resuming trading on December 15 [5] - Jiaze New Energy intends to invest approximately 3.557 billion yuan in a green hydrogen and methanol project in Heilongjiang [6] Group 3 - Shanghai Airport reports a 15.47% year-on-year increase in passenger throughput at Pudong International Airport for November [7] - Innovent Biologics achieves primary endpoint in a Phase IIb study of Obinutuzumab for systemic lupus erythematosus, with plans for a Phase III trial [8] - Saiyi Information leads a national major science and technology project on intelligent manufacturing systems and robotics [9] Group 4 - Yipin Hong's Qinxing Qingjie oral solution is approved as a national second-level protected traditional Chinese medicine [10] - Yipin Hong's stake in US-based Arthrosi Therapeutics is set to be acquired by Sobi for a total of up to 950 million USD [11] - Pudong Jinqiao announces the resignation of Chairman Wang Ying due to job transfer [12] Group 5 - Jiaze New Energy plans to invest in two wind power projects with a total estimated investment of approximately 2.366 billion yuan [13] - Jinpan Technology receives approval from the CSRC for issuing convertible bonds to unspecified investors [14] - Zoli Pharmaceutical intends to acquire a multi-trace element injection asset group for 356 million yuan [15] Group 6 - Jiuan Medical's US subsidiary receives pre-market notification from the FDA for multiple testing products [16][17] - Changfei Optical Fiber's subsidiary plans to participate in establishing an investment fund with a total subscription amount of 830 million yuan [18] - Chenfeng Technology's shareholder plans to reduce holdings by up to 3% of the company's shares [19][20][21][22]

Investment Ratings - The report maintains a "Buy" rating for both the power equipment and environmental protection sectors [1]. Core Views - The Central Economic Work Conference emphasizes the application of green electricity and promotes the development of hydrogen, ammonia, methanol, and energy storage, indicating a positive outlook for investment opportunities in green energy sectors in 2026 [3]. - Domestic energy storage saw significant growth in November, with newly installed capacity reaching 4.51GW/13.03GWh, reflecting a month-on-month increase of 57.14% in power and 74.66% in capacity [3][7]. - The report highlights the importance of hydrogen and green fuels as new growth points, with expectations for increased investment in these areas due to supportive policies and market conditions [4]. Summary by Sections Energy Storage - Domestic energy storage is experiencing a boom, with November's new installations showing a 45.95% year-on-year increase in power and a 49.6% increase in capacity [3][7]. - The report anticipates that independent energy storage tenders will maintain a good level in 2026, supported by a complete revenue model through energy markets and auxiliary services [3]. Hydrogen and Green Fuels - The report suggests that hydrogen and methanol will play a crucial role in the non-electric applications of green electricity, with significant investment expected in these areas [4]. - The development of zero-carbon parks and factories is also highlighted as a key initiative for 2026 [3]. Wind Power - The report notes that in 2024, onshore wind power installations are expected to reach 75.8GW, a year-on-year increase of 9.68%, while offshore wind installations are projected to be 4.0GW, a decrease of 40.85% [8]. - The bidding capacity for wind power equipment in 2024 is expected to be 164.1GW, a 90% increase year-on-year [13]. Lithium Battery - The report indicates that the demand for lithium batteries remains strong, with December's retail sales of new energy vehicles expected to show a bright performance despite a year-on-year decline of 17% [19]. - The supply chain for lithium batteries is expected to stabilize, with ongoing negotiations for long-term contracts and price adjustments [22][23].

Corporate Changes - Wang Ying, the chairman of Pudong Jinqiao, has resigned due to work transfer [2] - Xu Yinghui has become the new actual controller of Gu Ao Technology after a voting rights entrustment agreement [4][5] Profit Distribution - Xiangsheng Medical plans to distribute a cash dividend of 3 yuan per 10 shares for the first three quarters of 2025 [3] Investment Projects - Jiaze New Energy intends to invest approximately 3.557 billion yuan in a green hydrogen and methanol co-production project in Jixi City, Heilongjiang Province [6] - Longfei Optical Fiber's subsidiary plans to participate in establishing an investment fund with a total subscription amount of 830 million yuan [11] Financing Activities - Jinpan Technology has received approval from the China Securities Regulatory Commission to issue convertible bonds to unspecified investors [7] Acquisitions - Zoli Pharmaceutical has signed an agreement to acquire a multi-trace element injection asset group from Future Medicine for a total price of 356 million yuan [8] Product Approvals - Nine安 Medical's U.S. subsidiary has received pre-market notifications from the FDA for its multi-detection kits for various viruses [9] National Projects - Saiyi Information has been approved to lead a national major science and technology project focused on intelligent manufacturing systems and robotics [10]

Group 1 - Pudong Jinqiao's chairman Wang Ying has resigned due to job transfer, ceasing to hold positions as director, chairman, and committee member [2] - Xiangsheng Medical plans to distribute a cash dividend of 3 yuan per 10 shares to all shareholders based on the total share capital [3] - Gu Ao Technology's actual controller has changed to Xu Yinghui, with stock resuming trading on December 15 [4] Group 2 - Jiaze New Energy plans to invest approximately 3.557 billion yuan in a green hydrogen and aviation fuel chemical co-production project in Jixi City [5] - Jinpan Technology has received approval from the China Securities Regulatory Commission to issue convertible bonds to unspecified investors [6] - Zoli Pharmaceutical intends to acquire a multi-trace element injection asset group for a total price of 356 million yuan [7] Group 3 - Jiuan Medical's U.S. subsidiary has received pre-market notifications from the FDA for four and three-in-one testing products [8] - Saiyi Information has been approved for a national major science and technology project focusing on intelligent manufacturing systems and robotics [9] - Changfei Fiber's subsidiary plans to participate in establishing an investment fund with a total subscription amount of 830 million yuan [10] Group 4 - Chengfeng Technology's shareholder, Hangzhou Hongwo, plans to reduce its stake by up to 3% of the company's shares [12] - Minxin Co., Ltd.'s deputy general manager plans to reduce holdings by up to 220,000 shares, representing 0.3925% of the total share capital [13] - Xinle Energy's director plans to reduce holdings by up to 400,000 shares, accounting for 0.07% of the total share capital [14]